Mahnaz Yadollahi; Mehrdad Karajizadeh; Najmeh Bordbar; Zahra Ghahramani; Leila Shayan
Volume 10, Issue 3 , July 2022, , Pages 110-115
Abstract
Objective: To evaluate the effect of COVID-19 pandemic on the incidence and mortality rate of road trafficinjuries in Shiraz, Iran.Methods: This cross-sectional study was performed on the data of patients who admitted by road trafficaccidents 18 months before the outbreak of COVID-19 and 18 months after ...
Read More
Objective: To evaluate the effect of COVID-19 pandemic on the incidence and mortality rate of road trafficinjuries in Shiraz, Iran.Methods: This cross-sectional study was performed on the data of patients who admitted by road trafficaccidents 18 months before the outbreak of COVID-19 and 18 months after COVID-19 in the largest providerof trauma level 1 care services in southern Iran. SPSS 19 software was used to analyze the data.Results: A significant decrease of 12.8% was observed in the number of patients admitted by road trafficaccidents during the COVID-19 pandemic period compared to the same period before the pandemic (p<0.0001).But the death toll from road traffic accidents has increased significantly during the COVID-19 pandemic periodcompared to the same period before the pandemic (p=0.01).Conclusion: Due to the COVID-19 restrictions, it seems that factors such as restrictions on suburban travel,closure of public and recreational spaces, reduction of intra-city traffic, people staying at home and a significantreduction in injuries caused by traffic accidents, is reasonable. On the other hand, these restrictions, quarantines,and COVID disease itself can lead to confusion, anxiety, fear of infection, and thus avoid or delay the searchfor health care and increase mortality. Therefore, planning and policy-making is essential in order to preparethe correct guidance for seeking treatment.
Fariborz Ghaffarpasand; Mohammad Reza Saki; Nazanin Dadashpour; Zahra Ghahramani; Shahram Paydar
Volume 8, Issue 3 , July 2020, , Pages 133-134
Abstract
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) was first reported in Wuhan, China in December 2019 [1, 2] and was rapidly spread all over the world, being announced as a pandemic on March 11th, 2020 by the World Health Organization ...
Read More
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) was first reported in Wuhan, China in December 2019 [1, 2] and was rapidly spread all over the world, being announced as a pandemic on March 11th, 2020 by the World Health Organization (WHO) [3]. Approaching the mid of August, approximately 20 million people are infected worldwide and 720,000 have died due to the infection and its complications [4]. The virus causes respiratory infection and involves both the upper and lower respiratory tract as well as the gastrointestinal tract, hepatic, neurologic and renal systems [5].
